Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842933 · ClinicalTrials.gov registry record · Phase 4
Adrenal Insufficiency in Septic Shock
A Phase 4 study, sponsored by The Methodist Hospital Research Institute.
- Terminated
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT00842933 is a Phase 4 study that was terminated before completion, run by The Methodist Hospital Research Institute. The registered enrollment target is 32 participants.
The verdict
NCT00842933, a Phase 4 study, was terminated before completion, sponsored by The Methodist Hospital Research Institute.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
Randomized controlled trial evaluating the duration of steroid replacement therapy in patients with adrenal insufficiency and septic shock. Patients will be randomized to receive either hydrocortisone 50 mg IV every six hours for seven days (control) or hydrocortisone 50 mg IV every six hours until 24 hours after achievement of hemodynamic stability (MAP \> 65 mm Hg off of vasopressors).
Interventions
- DRUG Corticosteroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-05 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842933
The ClinicalTrials.gov registry entry for NCT00842933 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corticosteroid is the first listed.
NCT00842933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00842933 about?
NCT00842933 is a clinical study titled "Adrenal Insufficiency in Septic Shock". Randomized controlled trial evaluating the duration of steroid replacement therapy in patients with adrenal insufficiency and septic shock. Patients will be randomized to receive either hydrocortisone 50 mg IV every six hours for seven days (control) or hydrocortisone 50 mg IV every six hours until ...
What is the current status of trial NCT00842933?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2007-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00842933?
The interventions under investigation include: Corticosteroid (DRUG).
Who is sponsoring clinical trial NCT00842933?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.